Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 3/20 | 0.34 |
| ▸ | CA1 | P00915 | 3/20 | 0.34 |
| ▸ | CA2 | P00918 | 3/20 | 0.34 |
| ▸ | CA9 | Q16790 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL556846 | 0.92 | CYP1A2 (0.37) | CYP1A2MAPK1CA12CA1CA2 | |
| SCHEMBL4290820 | 0.91 | MAPT (0.36) | CYP1A2MAPK1CA12CA1CA2 | |
| SCHEMBL21359044 | 0.87 | CYP1A2 (0.37) | CYP1A2MAPK1CA12CA1CA2 | |
| SCHEMBL15015862 | 0.87 | CYP1A2 (0.43) | CYP1A2MAPK1CA12CA1CA2 | |
| SCHEMBL10706034 | 0.84 | ALDH1A1 (0.42) | CYP1A2MAPK1CA12CA1CA2 | |
| SCHEMBL25489387 | 0.83 | TDP1 (0.35) | ALDH1A1SMN1; SMN2LMNATSHRHSD17B10 | |
| SCHEMBL3427669 | 0.83 | MAPT (0.38) | CYP1A2MAPK1CA12CA1CA2 | |
| SCHEMBL9641431 | 0.83 | MAPT (0.38) | CYP1A2MAPK1CA12CA1CA2 | |
| SCHEMBL557796 | 0.81 | MAPT (0.45) | CYP1A2MAPK1CA12CA1CA2 | |
| SCHEMBL25956497 | 0.81 | CYP1A2 (0.33) | CYP1A2MAPK1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8778842-B2 | Sample lysis and coating of reaction surface | QIAGEN GMBH (DE) | 2014-07-15 | — | — | US | claimed |
| CN-101748117-B | Sample dissociation and coating of reaction surface | QIAGEN GMBH | 2014-03-26 | — | — | CN | claimed |
| EP-1856168-B1 | SAMPLE LYSIS AND COATING OF REACTION SURFACE | QIAGEN GMBH (DE) | 2011-04-27 | — | — | EP | claimed |
| US-20080299557-A1 | Sample Lysis and Coating of Reaction Surface | QIAGEN GMBH (DE) | 2008-12-04 | — | — | US | claimed |
| JP-60132934-A | — | — | None | — | — | JP | disclosed |
| CN-107540565-A | The preparation of N, N (two) alkyl amino alkyl (methyl) acrylamide or corresponding ester and its quaternary ammonium salt | 赢创罗姆有限公司 | 2018-01-05 | — | — | CN | disclosed |
| US-8778842-B2 | Sample lysis and coating of reaction surface | QIAGEN GMBH (DE) | 2014-07-15 | — | — | US | disclosed |
| CN-101748117-B | Sample dissociation and coating of reaction surface | QIAGEN GMBH | 2014-03-26 | — | — | CN | disclosed |
| EP-1856168-B1 | SAMPLE LYSIS AND COATING OF REACTION SURFACE | QIAGEN GMBH (DE) | 2011-04-27 | — | — | EP | disclosed |
| CN-101748117-A | Sample dissociation and coating of reaction surface | QIAGEN GMBH | 2010-06-23 | — | — | CN | disclosed |
| US-7592489-B2 | fluoroalkyl phosphate solution containing cationic copolymer of fluoroalkyl(meth)acrylate or perfluoroalkylether(meth)acrylate provides water repellency to surface without etching | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-09-22 | — | — | US | disclosed |
| US-20080299557-A1 | Sample Lysis and Coating of Reaction Surface | QIAGEN GMBH (DE) | 2008-12-04 | — | — | US | disclosed |
| US-4366299-A | Copolymers containing fluorine and their use for the water-repellent and oil-repellent treatment of various substrates | P C U K PRODUITS CHIMIQUES UGINE KUHLMANN (FR) | 1982-12-28 | — | — | US | disclosed |
| EP-0009154-B1 | COMPLEXES OF 9-HYDROXYALKYL-PURINES, PROCESSES FOR PREPARING THEM AND THERAPEUTICAL COMPOSITIONS CONTAINING THE COMPLEXES AS ACTIVE INGREDIENTS | Newport Pharmaceuticals International, Inc. (US) | 1982-12-08 | — | — | EP | disclosed |
| EP-0009155-B1 | 9-HYDROXYALKYL-PURINES, PROCESSES FOR PREPARING THEM AND THERAPEUTICAL COMPOSITION CONTAINING THE 9-HYDROXYALKYL-PURINES AS ACTIVE INGREDIENTS | Newport Pharmaceuticals International, Inc. (US) | 1982-11-17 | — | — | EP | disclosed |
| US-4221910-A | IMMUNOPOTENTIATORS, VIRICIDES, ANTILEUKEMIA AGENTS | NEWPORT PHARMACEUTICALS INTERNATIONAL, INC. (US) | 1980-09-09 | — | — | US | disclosed |
| US-4221909-A | P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1980-09-09 | — | — | US | disclosed |
| US-4221794-A | Method of imparting immunomodulating and antiviral activity | NEWPORT PHARMACEUTICALS INTERNATIONAL, INC. (US) | 1980-09-09 | — | — | US | disclosed |
| EP-0009155-A1 | 9-Hydroxyalkyl-purines, processes for preparing them and therapeutical composition containing the 9-hydroxyalkyl-purines as active ingredients | Newport Pharmaceuticals International, Inc. (US) | 1980-04-02 | — | — | EP | disclosed |
| EP-0009154-A1 | Complexes of 9-hydroxyalkyl-purines, processes for preparing them and therapeutical compositions containing the complexes as active ingredients | Newport Pharmaceuticals International, Inc. (US) | 1980-04-02 | — | — | EP | disclosed |